SCHEMBL4489837

SCHEMBL4489837

CC[C@H](C)Cn1c(-c2c(F)cc(OC)cc2F)c(Cl)nc(-c2ccn(C)n2)c1=O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
USP2 O75604 1/20 0.33
RECQL P46063 1/20 0.33
RAB9A P51151 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TP53 P04637 1/20 0.33
POLB P06746 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
FPR2 P25090 7/20 0.33
FPR1 P21462 5/20 0.33
TRAP1 Q12931 1/20 0.32
FGFR1 P11362 3/20 0.31
FGFR2 P21802 3/20 0.31
FGFR3 P22607 3/20 0.31
ADORA3 P0DMS8 1/20 0.31
MET P08581 1/20 0.31
IDO1 P14902 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3986813 0.86 TRAP1 (0.37) MAPTKDM4ENPC1USP2RECQL
SCHEMBL4486345 0.86 TRAP1 (0.37) MAPTKDM4ENPC1USP2RECQL
SCHEMBL4485590 0.78 TP53 (0.33) MAPTKMT2ATP53POLBSMN1; SMN2
SCHEMBL3993899 0.78 TP53 (0.33) MAPTKMT2ATP53POLBSMN1; SMN2
SCHEMBL4487540 0.70 FPR1 (0.33) FPR2FPR1
SCHEMBL3985848 0.70 FPR1 (0.34) FPR2FPR1
SCHEMBL4489281 0.69 KCNH2 (0.34) SMN1; SMN2
SCHEMBL4482238 0.67 LYN (0.32) MAPT
SCHEMBL4481630 0.67 ACLY (0.31)
SCHEMBL4492304 0.67 ACLY (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090186907-A1 Pyrazinones As Cellular Proliferation Inhibitors E.I. DUPONT DE NEMOURS AND COMPANY (US) 2009-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186907-A1 Pyrazinones As Cellular Proliferation Inhibitors MKI67, NR0B1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 MAPT 4590/4885KDM4E 3719/4885NPC1 698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.